elraglusib, a novel small molecule inhibitor of gsk-3
Published 1 year ago • 136 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
26:30
novel gsk-3 inhibitors for treating cns disorders
-
8:11
gsk-3 inhibitors - treatment of diabetes and cns disorders: targeting the substrate binding site
-
4:09
small molecule inhibitors (-nibs)
-
0:32
clinical activity of 9-ing-41, a small molecule selective glycogen synthase kinase-3 ... | rtcl.tv
-
17:24
the quest for small-molecule cancer immunotherapeutics
-
4:13
the next step in curing cancer - glycotreat
-
14:02
insulin signal transduction pathway
-
5:22
insulin (part 5) signalling that up-regulates glycogen synthesis
-
6:12
mark ji - 19mb055-small molecules that inhibit the β-catenin/bcl9 interaction
-
0:44
gsk-3b in neurodegeneration: cell signalling
-
27:24
a novel chronic neuronopathic gaucher disease model – approaching the human disease? - march 8 2021
-
5:20
glycogen synthase regulation
-
0:37
phospho gsk-3b in neurodegeneration: cell signalling
-
0:15
medical vocabulary: what does glycogen synthase kinase 3 mean
-
0:18
medical vocabulary: what does glycogen synthase kinase 3 mean
-
3:57
novel kinase inhibitor promising in nsclc
-
21:20
molecular heterogeneity of gliomas | implications for therapy design
-
9:16
glial cells (astrocytes, microglia, oligodendrocytes, schwann cells, ependymal cells)
-
17:26
chang chan: stochasticity and penetrance in cancer predisposition syndrome
-
56:37
neurology | glial cells: astrocytes, oligodendrocytes, schwann cells, ependymal cells, microglia
-
4:04
non-linear analysis of collagen in murine ovarian samples using second harmonic generation